Clinical Trial Update: Artificial Tears to Prevent Nasolacrimal Duct Obstruction in Patients Treated With Radioactive Iodine for Thyroid Cancer [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating artificial tears to prevent nasolacrimal duct obstruction in patients treated with radioactive iodine for thyroid cancer; curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasolacrimal Duct Obstruction
• Thyroid Cancer

Drugs mentioned

• Artificial Tears

Snippet

Sponsor: Vanderbilt University Medical Center | Conditions: Nasolacrimal Duct Obstruction, Thyroid Cancer | Phase 3 | Status: RECRUITING